03 Jan 2023 --- Amid a fast-growing market for dietary supplements containing cannabidiol (CBD) – the non-psychoactive compound found in cannabis – US regulators are reportedly stepping in to initiate regulation. The US Food and Drug Administration (FDA) is said to be on the brink of deciding how to regulate legal cannabis and if new legislation is needed. The Wall Street Journal (WSJ) has released a report after speaking with officials from the FDA and representatives from trade on how it is to go about regulating this “widely unregulated industry.”
